Kenneth Sawyer, JD

CEO, Co-Founder

• 45 years of pharmaceutical industry experience. 

• Former CEO of a publicly traded pharmaceutical company. 

• Represented the Pharmaceutical industry in front of the FDA, US Attorneys Office, and Congress.

• Chartered policies to legitimize generic drugs in the U.S. 

• Worked with the Clinton/Gore adminstration on implementing changes to health care. 

• Co-developed first generic drobonol for market.

Wei-wei Change, Ph.D.

President, Co-Founder

• 40+ years of pharmaceutical industry experience.

• Held senior management positions at Lederle and Warner-Lambert, both of which were acquired by Pfizer.

• Founding member of Rhodes Pharmaceutical, Anchen Pharmaceuticals, and Bharat Pharmaceutical.

• Rebuilt the Copley Pharmaceutical product pipeline, enabling its sale to Teva.

• Developed numerous drug products, new chemical entities, and generic drug formulations.

• Co-developed first generic drobonol for market.